SBIR Phase I: Advancing an Interactive Learning Platform by Integrating Multiplayer Game Technology

这个小型企业创新研究(SBIR)第一阶段项目通过整合多人游戏技术，推进了Syandus的互动学习平台。Syandus目前的互动交付平台允许制药公司和内容专家通过互动演示、讨论小组或自我指导学习向医生和患者交流复杂的概念。该项目提供的网络支持的协作为用户和内容专家之间的互动创造了机会，而不受地理位置的限制。将多人游戏技术整合到Syandus的平台中，需要创新地应用这项技术来服务于新的目的。该项目将制定功能要求，评估技术选择，并根据需要提供详细的设计计划和概念验证原型，以证明可行性。赛诺德斯目前正在与世界五大制药公司之一合作，为医生开发和提供创新的医学教育。在这一概念衍生出的第一个商业应用中，医生将能够远程连接全国内容专家，以比目前更具说服力的方式互动学习最新的最佳实践和医学科学。制药行业努力通过从国际和国家层面的思想领袖到地区医生思想领袖，再到执业医生和他们的患者的信息级联来传播医学创新和新的治疗方法。这一概念的预期结果将成为制药公司的学习工具，允许全国数十或数百名医生就疾病状态和适当的治疗进行互动对话。从长远来看，在教育领域，Syandus的技术可以用于开发更复杂的协作学习环境，在这种环境中，每个个人或团队负责大型互动系统的一部分。想象一下，一个学习工具，可以让来自全国各地的理科学生合作，优化细胞的功能。一些学生控制蛋白质合成，一些控制RNA合成，另一些学生控制营养物质进出质膜的流量。过程算法根据学生的输入控制每组的细胞输出。每一个都优化了它们的功能，以实现电池的整体性能。改造Syandus的现有平台，使其具有多用户能力，为远程学习过程增加了丰富的人类互动，将科学模型带入生活，并允许更大程度的知识传播。

This Small Business Innovation Research (SBIR) Phase I project advances Syandus's interactive learning platform by integrating multiplayer game technology. Syandus's current interactive delivery platform allows pharmaceutical firms and content experts to communicate complex concepts to physicians and patients through interactive presentations, discussion groups or self-directed learning. The addition of network-enabled collaboration afforded by this project creates the opportunity for interaction between users and content experts without the constraints of geography. The integration of multiplayer game technology into Syandus's platform requires the innovative application of this technology to serve a new purpose. This project will develop the functional requirements, assess technology options and deliver a detailed design plan and proof of concept prototypes as needed to demonstrate feasibility. Syandus is currently working with one of the top five pharmaceutical companies in world to develop and deliver innovative medical education to physicians. In the first business application derived from this concept, physicians will be able to remotely connect with nationwide content experts to interactively learn the latest best practices and medical science in a more compelling way than currently available. The pharmaceutical industry strives to communicate medical science innovation and new treatment methods through an information cascade from international and national level thought leaders, to regional physician thought leaders, to practicing physicians and their patients. The anticipated results from this concept will be a learning tool for pharmaceutical companies that allow tens or hundreds of physicians nationwide to have an interactive dialog about a disease state and appropriate treatment. Longer term, in the educational realm, Syandus's technology could be used to develop more sophisticated collaborative learning environments where each individual or group is responsible for one part of a large interactive system. Imagine a learning tool that allows science students from around the country to collaborate to optimize the function of a cell. Some students control protein synthesis, some RNA synthesis, others the flux of nutrients in and out of the plasma membrane. Process algorithms control the cellular outputs from each group based on students' inputs. Each optimizes their function for the overall performance of the cell. Transforming Syandus's existing platform with multi user capability adds rich human interaction into the remote learning process, brings scientific models to life, and allows greater dissemination of knowledge.